Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Emily A Edelman"'
Autor:
Jens Rueter, Anny T. Fenton, Elizabeth Scharnetzki, Emily A Edelman, Kate Reed, Eric C. Anderson, Andrey Antov, Paul K. J. Han
Publikováno v:
Patient Education and Counseling. 104:3-11
Objective To compare clinicians’ and patients’ preferences for disclosure of genomic tumor testing (GTT) results; to determine the sensitivity of these disclosure preferences to uncertainty about the actionability of results; and to explore facto
Autor:
Emily R. Edelman, Samira A. Amirazizi, Daniel K. Feinberg, Matthew Quirk, Jennifer Scheller, Carlos R. Pagán, Jamie Persoon
Publikováno v:
TESOL Journal. 13
Autor:
Alexandra Hinton, Tania D. Strout, Christine W. Lary, Jens Rueter, Eric C. Anderson, Andrey Antov, Paul K. J. Han, Emily A Edelman, Kate Reed, Petra Helbig
Publikováno v:
Psychology, Health & Medicine. 26:805-817
Novel medical technologies, like large-panel genomic tumor testing (GTT), offer great promise but also substantial uncertainty regarding their clinical value and appropriate use. The goal of this study was to understand how clinicians' perceived unce
Publikováno v:
Seminars in Oncology Nursing. 35:22-33
Objective To provide an overview of key considerations for somatic testing for the purpose of targeting cancer treatment. Data Sources Literature; research reports. Conclusion Genomic testing of cancer cells to identify variants that drive the carcin
Autor:
Emily A Edelman, E Kate Reed
Publikováno v:
Journal of the American Association of Nurse Practitioners. 31:327-329
Family history risk assessment can identify individuals at increased risk of colorectal cancer (CRC) who would benefit from earlier or more frequent CRC screening. Clinicians should evaluate the patient's family history as well as personal history to
Autor:
Paige C. Tanner, Laura Nicholson, Eleanor K Reed, Sean C. McConnell, Emily A Edelman, Linda Steinmark, Katherine Aj Taber, Therese M Ingram
Publikováno v:
Personalized medicine. 16(3)
Given the rapid growth in genomic tests and targeted therapeutics, clinicians are likely to benefit from additional precision medicine education. Aim: This study evaluated the engagement and effectiveness of two interactive, case-based educational mo
Publikováno v:
American journal of speech-language pathology. 28(2)
Purpose The aim of this study was to assess knowledge, self-rated confidence, and perceived relevance of genetics in the clinical practice of audiologists and speech-language pathologists (SLPs) toward a better understanding of the need for genetics
Publikováno v:
Journal of the American Association of Nurse PractitionersReference. 31(1)
Genetic and genomic information has the potential to improve patient care and outcomes by improving clinicians' ability to identify patients at increased risk of disease and, in some cases, personalize treatment and management. However, many clinicia
Autor:
E Kate Reed, Emily A Edelman
Publikováno v:
Journal of the American Association of Nurse Practitioners. 30(10)
Increasingly, individuals are interested in genetic testing to find out if they are at increased risk for breast cancer and other diseases. Through direct-to-consumer genetic testing, people can receive information about many different traits, includ
Autor:
James O'Leary, Bruce K. Lin, Siobhan M. Dolan, Kevin S. Hughes, Emily A Edelman, Vaughn Edelson, Michele A. Lloyd-Puryear, Joseph D. McInerney, Brian Drohan, Joan Scott, Penny Kyler
Publikováno v:
Personalized medicine. 10(3)
In the age of genomic medicine, family health history (FHH) remains an important tool for personalized risk assessment as it can inform approaches to disease prevention and management. In primary care, including in prenatal settings, providers recogn